At EULAR 2025, our speakers explored the clinical relevance of CRP in rheumatic diseases. The session highlighted that both elevated and normal CRP levels can be seen in active disease and may impact treatment response. The discussion reinforced the need for a more personalised approach to guide therapy and improve patient outcomes
